Product
AR100DP1
1 clinical trial
2 indications
Indication
DermatitisIndication
AtopicClinical trial
A Phase I/IIa Open-Label, Dose-Escalation Study to Determine the Safety, Tolerability, and Efficacy of AR100DP1 in Healthy Subjects, and Subjects With Mild to Moderate Atopic DermatitisStatus: Terminated, Estimated PCD: 2021-12-29